07:08 AM EDT, 05/09/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) reported Q1 adjusted earnings Friday of $1.70 per diluted share, up from $1.21 a year earlier.

Analysts polled by FactSet expected $1.38.

Revenue for the quarter ended March 31 was $197.1 million compared with $137.4 million a year earlier.

Analysts surveyed by FactSet expected $180.6 million.

The company said it now expects 2025 adjusted EPS of $6.27 to $6.62 on revenue of $768 million to $793 million versus its prior outlook ranges of $6.12 to $6.49 and $756 million to $776 million, respectively.

The consensus is for $6.34 and $769.6 million, respectively.

ANI shares were up 3.5% in recent premarket activity.